Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLUNYSE:EXRNYSE:PED On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLUBELLUS Health$14.74$14.62$6.38▼$14.76$1.87B0.193.08 million shs3.45 million shsEXRExtra Space Storage$147.44+1.1%$147.68$121.03▼$184.87$30.95B1.111.05 million shs1.39 million shsPEDPEDEVCO$0.65-1.9%$0.63$0.47▼$1.10$60.95M0.41139,887 shs239,565 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLUBELLUS Health0.00%0.00%0.00%0.00%0.00%EXRExtra Space Storage+1.16%-1.15%-2.29%-0.25%-5.13%PEDPEDEVCO-1.95%-10.37%+2.07%-6.03%-27.67%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLUBELLUS HealthN/AN/AN/AN/AN/AN/AN/AN/AEXRExtra Space Storage4.1604 of 5 stars2.33.01.74.03.42.50.6PEDPEDEVCO3.3533 of 5 stars3.50.00.00.00.61.73.1Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLUBELLUS Health 0.00N/AN/AN/AEXRExtra Space Storage 2.50Moderate Buy$159.298.03% UpsidePEDPEDEVCO 3.00Buy$1.63148.36% UpsideCurrent Analyst Ratings BreakdownLatest BLU, PED, CTP, and EXR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/24/2025EXRExtra Space StorageBNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold6/24/2025EXRExtra Space StorageBNP Paribas ExaneSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$156.006/13/2025EXRExtra Space StorageJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$160.00 ➝ $162.005/28/2025EXRExtra Space StorageMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$141.00 ➝ $153.005/20/2025PEDPEDEVCOD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$1.50 ➝ $1.505/16/2025EXRExtra Space StorageBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$181.00 ➝ $178.005/13/2025EXRExtra Space StorageBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$155.00 ➝ $161.005/13/2025EXRExtra Space StorageBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$61.00 ➝ $55.005/12/2025EXRExtra Space StorageScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Outperform ➝ Sector Outperform$149.00 ➝ $166.005/1/2025EXRExtra Space StorageRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Perform ➝ Sector Perform$163.00 ➝ $160.005/1/2025EXRExtra Space StorageEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetIn-Line ➝ In-Line$144.00 ➝ $149.00(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLUBELLUS Health$15K124,613.93N/AN/A$3.09 per share4.77EXRExtra Space Storage$3.26B9.61$7.89 per share18.69$70.10 per share2.10PEDPEDEVCO$40.17M1.49$0.11 per share6.21$1.13 per share0.58Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLUBELLUS Health-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/AEXRExtra Space Storage$854.68M$4.3134.2117.683.5427.84%6.11%3.21%7/29/2025 (Estimated)PEDPEDEVCO$260K$0.1932.739.35N/A6.57%1.58%1.39%N/ALatest BLU, PED, CTP, and EXR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/29/2025Q2 2025EXRExtra Space Storage$2.06N/AN/AN/A$719.43 millionN/A4/29/2025Q1 2025EXRExtra Space Storage$1.96$2.00+$0.04$2.00$705.12 million$820.00 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLUBELLUS HealthN/AN/AN/AN/AN/AEXRExtra Space Storage$6.484.40%N/A150.35%1 YearsPEDPEDEVCON/AN/AN/AN/AN/ALatest BLU, PED, CTP, and EXR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/22/2025EXRExtra Space Storagequarterly$1.624.48%6/16/20256/16/20256/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLUBELLUS HealthN/A33.4233.42EXRExtra Space Storage0.850.330.33PEDPEDEVCON/A2.102.10Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLUBELLUS Health90.37%EXRExtra Space Storage99.11%PEDPEDEVCO3.26%Insider OwnershipCompanyInsider OwnershipBLUBELLUS Health24.17%EXRExtra Space Storage1.36%PEDPEDEVCO70.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLUBELLUS Health74126.81 million96.16 millionNot OptionableEXRExtra Space Storage8,012212.21 million209.33 millionOptionablePEDPEDEVCO1091.34 million26.31 millionNot OptionableBLU, PED, CTP, and EXR HeadlinesRecent News About These CompaniesRoth Capital Has Pessimistic Outlook of PEDEVCO Q2 EarningsJune 9, 2025 | marketbeat.comPEDEVCO To Participate In The 2025 Louisiana Energy ConferenceMay 23, 2025 | accessnewswire.comAPedevco Corp. (PED) Reports Break-Even Earnings for Q1May 15, 2025 | zacks.comPEDEVCO Corp.: PEDEVCO Announces Q1 2025 Financial Results and Operations UpdateMay 15, 2025 | finanznachrichten.dePEDEVCO Announces Q1 2025 Financial Results and Operations UpdateMay 15, 2025 | accessnewswire.comAShould Value Investors Buy Pedevco (PED) Stock?May 7, 2025 | zacks.comPEDEVCO Announces 2024 Financial ResultsMarch 31, 2025 | accessnewswire.comAPEDEVCO Provides Permian Basin Operational UpdateMarch 11, 2025 | accessnewswire.comAPEDEVCO to Participate in the 37th Annual ROTH ConferenceMarch 10, 2025 | accessnewswire.comARoth MKM Reaffirms Their Buy Rating on Pedevco (PED)March 5, 2025 | markets.businessinsider.comPEDEVCO Corp.: PEDEVCO Announces Entry into Joint Development Agreement with Large Private Equity-Backed D-J Basin E&P CompanyMarch 3, 2025 | finanznachrichten.dePedevco enters joint development agreement with D-J Basin E&P companyMarch 3, 2025 | markets.businessinsider.comPEDEVCO Announces Entry into Joint Development Agreement with Large Private Equity-Backed D-J Basin E&P CompanyMarch 3, 2025 | accessnewswire.comA3 Oil & Gas Equipment Stocks Set to Gain From a Promising IndustryFebruary 27, 2025 | zacks.comPEDEVCO Corp. (NYSE:PED) CAO Sells $19,550.00 in StockJanuary 28, 2025 | insidertrades.comPedevco corp officer sells shares worth $69,218January 27, 2025 | msn.comPedevco Corp CEO John Douglas Schick sells $141,182 in stockJanuary 27, 2025 | msn.comPEDEVCO Announces Appointment of New Chief Executive Officer, New Chief Commercial Officer, and Board of Director ChangesDecember 11, 2024 | accesswire.comAPEDEVCO Corp.: PEDEVCO Announces Q3 2024 Financial Results and Operations UpdateNovember 15, 2024 | finanznachrichten.dePedevco Corp. (PED) Q3 Earnings Match EstimatesNovember 14, 2024 | zacks.comPEDEVCO Announces Q3 2024 Financial Results and Operations UpdateNovember 14, 2024 | accesswire.comANew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Top Dividend Stocks Analysts Are Bullish on Right NowBy Chris Markoch | June 6, 2025View 3 Top Dividend Stocks Analysts Are Bullish on Right NowQualcomm: What Monday’s Jump Tells Us About the Stock's ProspectsBy Sam Quirke | June 10, 2025View Qualcomm: What Monday’s Jump Tells Us About the Stock's ProspectsOuster Soars 27% as DoD Grants First 3D LiDAR Approval for DronesBy Leo Miller | June 14, 2025View Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones3 Tech Focused ETFs to Watch as the Market Nears All-Time HighsBy Ryan Hasson | June 11, 2025View 3 Tech Focused ETFs to Watch as the Market Nears All-Time HighsIgnore the Noise—Samsara Stock Is Still a Strong BuyBy Sam Quirke | June 12, 2025View Ignore the Noise—Samsara Stock Is Still a Strong BuyBLU, PED, CTP, and EXR Company DescriptionsBELLUS Health NASDAQ:BLUBELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.Extra Space Storage NYSE:EXR$147.44 +1.58 (+1.08%) As of 06/30/2025 03:58 PM EasternExtra Space Storage Inc., headquartered in Salt Lake City, Utah, is a self-administered and self-managed REIT and a member of the S&P 500. As of December 31, 2023, the Company owned and/or operated 3,714 self-storage stores in 42 states and Washington, D.C. The Company's stores comprise approximately 2.6 million units and approximately 283.0 million square feet of rentable space operating under the Extra Space, Life Storage and Storage Express brands. The Company offers customers a wide selection of conveniently located and secure storage units across the country, including boat storage, RV storage and business storage. It is the largest operator of self-storage properties in the United States.PEDEVCO NYSE:PED$0.65 -0.01 (-1.95%) As of 06/30/2025 03:59 PM EasternPEDEVCO Corp., an oil and gas company, focuses on the acquisition, development, and production of oil and natural gas assets in the United States. It holds interests in the Permian Basin asset covering an area of approximately 22,721 net acres located in New Mexico; and D-J Basin asset covering an area of approximately 19,214 net acres located in Wyoming. The company is headquartered in Houston, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Why BigBear.ai Could Rally 100% and Catch Palantir Soon Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Alphabet’s Waymo and Services Beginning to Feel the Pressure? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
